Celeste Miller, MD
Pain Medicine · Davenport, IANPI 1255306932
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AbbVie at 41.1% of the total. That places this record below the midpoint for pain medicine clinicians in IA, where the typical reported total is $2,859.
Across 90 payments — averaging $19.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$706
- SPR Therapeutics, Inc$149
- Axsome Therapeutics, Inc.$120
- Teva Pharmaceuticals USA, Inc.$118
- Lilly USA, LLC$112
- Pfizer$86
- plus $429 from 11 others
What the payments were for
- Food & beverage$1,719100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 52 | $706 |
| SPR Therapeutics, Inc | 1 | $149 |
| Axsome Therapeutics, Inc. | 1 | $120 |
| Teva Pharmaceuticals USA, Inc. | 1 | $118 |
| Lilly USA, LLC | 6 | $112 |
| Pfizer | 5 | $86 |
| Amgen | 4 | $80 |
| Biodelivery Sciences International, Inc. | 5 | $79 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $59 |
| Collegium Pharmaceutical, Inc. | 4 | $52 |
| Averitas Pharma Inc. | 2 | $40 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $33 |
| Nevro Corp. | 2 | $31 |
| GRT US Holding, Inc. | 1 | $17 |
| Novo Nordisk | 1 | $15 |
| Almatica Pharma LLC | 1 | $13 |
| Boston Scientific | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRINT PNS System$149
- Symbravo$120
- AJOVY$118
How this compares
$1,719 in reported general payments places this provider in the 45th percentile of 31 pain medicine providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 23 | $2,952 |
| Celecoxib | 47 | $1,457 |
| Gabapentin | 43 | $1,144 |
| Pregabalin | 70 | $1,042 |
| Duloxetine Hcl | 57 | $944 |
| Cyclobenzaprine Hcl | 14 | $195 |
| Meloxicam | 32 | $165 |
| Tizanidine Hcl | 29 | $160 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Davenport
- John DooleyDavenport$6K
- Timothy MillerDavenport$4K
- Timothy MavesDavenport$190
- Garry ClarkSioux City$189K
- Jolene SmithClive$85K
- Daniel MoyseDes Moines$40K
- Christopher StalveyWest Des Moines$14K
- William ChangIowa City$9K
- Joysree SubramanianIowa City$9K
- John RayburnDes Moines$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.